Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
|
|
OPKO HEALTH, INC. (OPK)
|
Add to portfolio |
|
|
|
| Price: |
$4.93
| | Metrics |
| OS: |
773.1
|
M
| |
|
|
| Market cap: |
$3.81
|
B
| |
|
|
|
Net debt:
|
$105
|
M
| |
|
|
|
EV:
|
$3.92
|
B
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($137)
|
M
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 1,004.2 | 1,774.7 | 1,435.4 | 901.9 | 990.3 | 966.0 | 1,117.5 | 491.7 |
| Revenue growth | -43.4% | 23.6% | 59.1% | -8.9% | 2.5% | -13.6% | 127.3% | 439.6% |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 235.2 |
| Gross profit | 1,004.2 | 1,774.7 | 1,435.4 | 901.9 | 990.3 | 966.0 | 1,117.5 | 256.5 |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 52.2% |
| Selling, general and administrative | 372.7 | 468.9 | 355.6 | 343.3 | 358.3 | 414.6 | 407.3 | 196.6 |
| Research and development | 73.9 | 76.9 | 75.3 | 117.9 | 125.6 | 126.4 | 113.9 | 99.5 |
| EBITA | -157.4 | 36.9 | 113.6 | -119.8 | -81.5 | -191.8 | -39.8 | -77.6 |
| EBITA margin | -15.7% | 2.1% | 7.9% | -13.3% | -8.2% | -19.9% | -3.6% | -15.8% |
| Amortization of intangibles | 87.8 | 50.3 | 56.4 | 64.8 | 67.9 | 71.5 | 64.4 | 28.0 |
| EBIT | -245.2 | -13.4 | 57.2 | -184.6 | -149.4 | -263.2 | -104.2 | -105.6 |
| EBIT margin | -24.4% | -0.8% | 4.0% | -20.5% | -15.1% | -27.3% | -9.3% | -21.5% |
| Pre-tax income | -391.5 | -14.0 | 48.7 | -305.0 | -177.3 | -271.9 | -96.8 | -138.0 |
| Income taxes | -63.5 | 15.5 | 17.6 | 7.1 | 38.7 | -18.9 | -56.1 | -113.7 |
| Tax rate | 16.2% | | 36.2% | | | 6.9% | 58.0% | 82.4% |
| Net income | -328.4 | -30.1 | 30.6 | -314.9 | -153.0 | -305.3 | -48.4 | -30.0 |
| Net margin | -32.7% | -1.7% | 2.1% | -34.9% | -15.5% | -31.6% | -4.3% | -6.1% |
| |
| Diluted EPS | ($0.46) | ($0.05) | $0.05 | ($0.53) | ($0.27) | ($0.55) | ($0.09) | ($0.06) |
| Shares outstanding (diluted) | 719.1 | 648.1 | 640.7 | 595.5 | 563.1 | 559.2 | 555.6 | 488.1 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|